Abbott Laboratories (ABT) Operating Expenses (2009 - 2026)

Abbott Laboratories has disclosed Operating Expenses across 18 years of filings, most recently posting $10.9 billion for Q2 2026.

• In Q2 2026, Operating Expenses rose 19.91% year-over-year to $10.9 billion; the TTM figure through Jun 2026 stood at $39.2 billion (up 10.24% YoY), while the FY2025 annual figure was $36.3 billion, up 3.27% from the prior year.
• Operating Expenses came in at $10.9 billion for Q2 2026 at Abbott Laboratories, up from $9.8 billion in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $10.9 billion in Q2 2026 to a low of $8.2 billion in Q1 2023.
• Average Operating Expenses over 5 years is $8.9 billion, with a median of $8.8 billion recorded in 2022.
• Year-over-year, Operating Expenses dropped 8.29% in 2023 and gained 19.91% in 2026.
• Over 5 years, Operating Expenses stood at $8.8 billion in 2022, then fell by 3.71% to $8.5 billion in 2023, then gained by 7.11% to $9.1 billion in 2024, then climbed by 1.6% to $9.2 billion in 2025, then gained by 18.38% to $10.9 billion in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $10.9 billion in Q2 2026, $9.8 billion in Q1 2026, and $9.2 billion in Q4 2025.